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Abstract
Studies of racial disparities in hospital-level patient safety outcomes typically apply a race-
common approach to risk adjustment. Risk factors specific to a minority population may not be 
identified in a race-common analysis if they represent only a small percentage of total cases. This 
study identified patient comorbidities and characteristics associated with the likelihood of a 
venous catheter–related bloodstream infection (Agency for Healthcare Research and Quality 
Patient Safety Indicator 7 [PSI7]) separately for blacks and whites using race-specific logistic 
regression models. Hospitals were ranked by the racial disparity in PSI7 and segmented into 4 
groups. The analysis identified both black- and white-specific risk factors associated with PSI7. 
Age showed race-specific reverse association, with younger blacks and older whites more likely to 
have a PSI7 event. These findings suggest the need for race-specific covariate adjustments in 
patient outcomes and provide a new context for examining racial disparities.
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Patient Safety Indicators (PSIs) were developed by the Agency for Healthcare Research and 
Quality (AHRQ) as a means to detect events that had a high likelihood of representing 
medical errors and could be identified using hospital administrative data.1–3 Studies have 
applied the suite of PSIs to large samples of hospital discharges in order to address patient 
safety events and the quality of hospital care.2–7 Studies examining health disparities have 
compared PSI7 (venous catheter–related bloodstream infection) rates and risks between race 
groups and often suggest unequal quality of care as the main reason for racial differences in 
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adverse outcomes and safety events.8,9 However, the causes of health disparities likely 
involve a complex relationship between demographic, socioeconomic, biological, and 
structural factors in addition to actual differences in quality of care.10
Adverse events from medical and surgical care do not result only from health care provider 
errors but also from acuity of patients’ illnesses.11 For example, comorbidities such as 
congestive heart failure (CHF), weight loss, diabetes, and electrolyte disorder are associated 
with increased likelihood of a patient safety event during hospitalization.4 Some of these 
comorbidities occur earlier and more frequently in blacks than whites.12,13 In a study of 
health disparities in sepsis, blacks had a 25% greater likelihood of having a sepsis diagnosis 
compared with whites and were more likely to have comorbid conditions (chronic renal 
failure, diabetes, and alcohol abuse) associated with sepsis.14
Therefore, blacks and whites may have different profiles and severity of comorbidities, 
which may explain some of the observed racial disparities in adverse outcomes and safety 
events. However, most studies of disparities in patient safety events typically have focused 
on hospital-level factors and concluded that racial disparities in patient outcomes result more 
from variation in quality between hospitals than from variation within hospitals.8,15 As a 
consequence, studies of patient safety in US hospitals have evaluated differences in hospital 
characteristics, risk adjusting for demographic and clinical characteristics and comorbidities.
6,9,16,17
 Racial disparities in the risk-adjusted rates of patient safety events in these studies, 
such as infection resulting from medical care, postoperative hemorrhage, and postoperative 
complications, were small and not significant for almost all the hospitals.4,6,16 Because these 
studies did not adjust for the size and relative proportion of black/white discharges, 
Metersky et al used abstracted data on Medicare patients that included the percentage of 
black patient discharges in their analysis and concluded that adverse drug events and 
nosocomial infections among black patients are associated with a greater risk profile and a 
higher percentage of black patient discharges. Although these studies considered contextual 
effects and adjusted for between-hospital variance, lack of specific criteria for hospital 
sampling and risk adjustment that does not consider the variation in patient characteristics 
within hospitals may lead to biased estimates and conclusions on racial disparities.
It is important to note that the proportions of black and white patient discharges are not the 
same across hospitals, that the frequency of reported safety events varies across and within 
hospitals for both races, and that small hospitals in specific geographic locations may have 
substantially fewer discharges for a particular racial group. In addition, adverse outcomes 
such as the AHRQ PSIs are relatively rare events, and hospital inclusion criteria must be 
applied to ensure that there are sufficient cases in the appropriate denominator to compute 
valid rates and sufficient cases of race-specific outcomes to populate the numerators. If the 
inclusion criteria do not ensure sufficient representation of both races in the hospital sample, 
the outcomes for minority race groups may be underestimated.
In most studies, the additive model is used to evaluate racial disparities, with race included 
in the model as one of the explanatory variables, with the assumption that race has a 
“common effect” across other attributes in the model.18 Failure to consider that patient 
characteristics may have different effects in blacks and whites may mask racial differences 
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in a safety event. When assessing patient safety events in general, studies have adjusted for 
patient baseline characteristics; some of these characteristics such as hypertension and 
diabetes affect blacks more than whites and may influence inpatient care for blacks and 
white differently. It is important to understand whether comorbidities used for risk 
adjustment affect a patient safety event equally for blacks and whites. Therefore, this study 
sought to identify patient comorbidities and characteristics associated with the likelihood of 
an AHRQ-PSI7 separately for blacks and whites using race-specific models, an approach 
that has not been used previously in PSI7 research.
Methods
Design and Data Source
A retrospective cross-sectional analysis was conducted of patients discharged from Florida 
acute hospitals from 2005 to 2009. Discharge data were obtained from the Florida Agency 
for Health Care Administration and derived from the Florida Inpatient Discharge Database. 
The data include diagnosis, procedure, and demographic information from 206 short-term 
acute hospitals.
Outcome Variable of Interest
The outcome variable of interest was defined as infection caused by medical care or venous 
catheter–related bloodstream infection, one of the PSIs developed by AHRQ. PSIs are used 
to screen for potential patient safety events in hospital discharge data and have been used to 
assess disparities in safety indicators.9 The PSIs are reliable measures, with good construct 
validity and stability over time. PSI7 has been shown to be correlated with most of the other 
PSI indicators, and studies have suggested that it can be used as a quick index of general 
patient safety status.19 For discharges before October 1, 2007, PSI7 was defined as 
infections related to hospital stay; from October 1, 2007, onward, it was defined as central 
venous catheter–related bloodstream infection.20 Using the AHRQ PSI software,21 PSI7 
cases were identified accounting for these inclusion criteria: all discharges 18 years of age 
and older; pregnancy or childbirth discharges if younger than 18 years with International 
Classification of Diseases, Ninth Revision, Clinical Modification diagnostic codes 99662 
and 9993; cases without diagnosis of infection present on admission; with a hospital stay 
longer than 1 day; and without immunocompromised state or cancer diagnoses. The data 
selection flow chart is shown in Figure 1.
Study Sample
Specific criteria were used to select hospitals for inclusion and to ensure that the hospitals 
had sufficient PSI7 cases to enable meaningful analysis and comparison of outcomes across 
hospitals and between white and black patients within hospitals. The criteria included having 
at least 10 black and white PSI7 discharges, or at least 25 white PSI7 and 5 black PSI7 
discharges, or at least 30 PSI7 discharges total and 10 000 black discharges. Of the 206 
hospitals, 103 hospitals met the criteria and were selected. For each hospital included, white 
and black patient discharges were aggregated to determine race-specific discharges and race-
specific PSI7 rates. The hospitals were rank ordered and segmented into 4 groups based on 
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the black/white PSI7 rate ratio to provide a range of PSI7 rate gaps across Florida hospitals, 
which were used to describe the hospitals and patient characteristics.
The first group’s black/white PSI7 rate ratio was 0.6, representing hospitals where black 
PSI7 rates were lower than white rates; the second group’s black/white PSI7 rate ratio was 
0.95, representing hospitals with nearly identical black/white PSI7 rates; the third group’s 
black/white PSI7 rate ratio was 1.34 representing hospitals where black PSI7 rates were 
higher than white rates; the fourth group’s black/white PSI7 rate ratio was 2.53, representing 
hospitals where black rates were much higher than white rates.
A total of 8 analytic samples were created: 4 for blacks and 4 for whites. The sizes of the 
black and white samples representing the 4 hospital groups are shown in Table 1. The total 
study population included 5 236 045 discharges.
Explanatory Variables of Interest
The explanatory variables of particular interest were the comorbidities. Comorbidities were 
identified using the Elixhauser Comorbidity Index.22 The index includes 30 comorbidity 
measures for risk adjusting and predicting outcomes. In this study, 4 comorbidities—cancer 
(meta-static cancer, solid tumor, and lymphoma) and AIDS—were excluded because of their 
influence on PSI7. Also, 26 comorbid conditions were included in the analyses as a separate 
dichotomous variable. In addition to the comorbidities, other patient characteristics included 
were age as a continuous variable, sex, admission type (emergency, urgent, elective, and 
trauma), and pay source (Medicare, Medicaid, commercial insurance, Champus/Veterans 
Administration, and self-pay/underinsured). The reference groups were men for sex, elective 
admission for admission type, and commercial insurance for pay source.
Statistical Analysis
The PSI7 racial rate gap, represented by the 4 PSI7 rate ratios for the 4 hospital groups were 
used as the basis of describing the sample. All analyses were performed separately for the 8 
race-specific analytic samples (ie, 4 separate analyses for black and white patients in each of 
the 4 hospital groups). Descriptive analyses by hospital groups included the following: total 
discharges, percentage of black and white discharges, PSI7 rates/10 000 discharges, the ratio 
of black/white PSI7 rate, average age, and average length of stay (LOS) for all patients and 
for patients with PSI7. Potential correlation between comorbidities within each hospital 
group was assessed using Spearman correlation and variance inflation factor. There was no 
significant correlation between the comorbidities, and all 26 comorbidities were included in 
the adjusted analyses. Hospital-level effects within groups were checked with multilevel 
analyses. There was no significant hospital-level effect because hospitals in each group have 
similar PSI7 rates; hence, logistic regression was applied. Logistic regression was used to 
assess the association of comorbidities with PSI7, adjusting for age, sex, health insurance, 
and admission type. LOS was not included in the model because it is an endogenous 
explanatory variable that is both a cause and effect of PSI7 and its inclusion in the model 
could bias the estimates.23,24 In all, 8 separate logistic models were used to assess racial 
differences in PSI7 for blacks and whites in the 4 hospital groups. Comorbidities related to 
PSI7 were grouped to determine patterns that may explain racial differences in PSI7 risks 
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within hospital groups. The discriminating strength of the models was assessed with C 
statistics, which ranged between 0.65 and 0.73. For descriptive statistics, we used Excel 
(Microsoft Corporation, Redmond, WA). Logistic regression analyses were performed using 
SAS version 9.2 (SAS Institute Inc, Cary, NC).
Results
Characteristics of Hospital Groups
The black PSI7 rates increase consistently across the 4 groups, whereas the white rates 
decrease, though not in a perfectly linear fashion. Group 4 had the highest black rate and the 
lowest white rate, thus reflecting the largest racial disparity (Table 1).
The 5-year average of hospital discharges decreased linearly with the largest 5-year average 
in group 1 and the lowest in group 4. The percentage of total discharges represented by black 
patients increased across the groups, whereas the percentage of white discharges decreased 
steadily across the groups. No significant racial differences were apparent in LOS either for 
discharges with a PSI7 or all discharges. However, the LOS for patients who had PSI7 was 
nearly 3 times longer than the average LOS for all patients across all groups. On average, 
white patients were approximately 10 to 11 years older than blacks. However, the age gap 
for white and black PSI7 patients was highest in group 3 (15.9 years) and group 4 (17.5 
years), where the infection rates for blacks were highest compared with whites. On average, 
these 2 groups have the youngest black patients and the oldest white patients.
Adjusted Results of Risk Factors for PSI7
The logistic regression models revealed 3 groups of comorbidities and characteristics 
associated with the likelihood of a PSI7 event (Tables 2 and 3). A primary cluster of 
significant factors common to both black and white patients was found in most of the 
hospital groups. Comorbid weight loss and electrolyte disorder are significant in all 8 
groups, coagulopathy in 7 of 8 groups, and paralysis in 5 of 8 groups. Paralysis is significant 
for blacks in hospital groups with the lowest PSI7 rate gap (groups 1 and 2) and for whites in 
groups with the highest PSI7 rate gap (groups 1, 2, and 3). The primary cluster also includes 
emergency admission as a significant factor for all 8 groups and Medicare insurance for 7 of 
8 groups.
A secondary cluster of risk factors that are race specific was identified. For whites, these 
included chronic blood loss/anemia, peptic ulcer/bleeding, diabetes with complications, and 
trauma admission. Notably, these secondary factors are found only in white groups 1 and 2, 
where PSI7 rates are highest. The secondary cluster for blacks includes perivascular disease, 
neurological disorders, and renal failure. Medicaid insurance was significant in 3 of 4 black 
groups.
A secondary cluster of race-common factors was identified; unlike the primary cluster, these 
factors typically were significant in only 1 or 2 groups. Drug abuse was significant for 
whites in groups 1 and 2 and for blacks in group 4, and therefore, it is an important risk 
factor for both races in groups where the PSI7 rates were highest. CHF was significant for 
whites in groups 1, 2, and 3 and for blacks in group 2. This suggests that, although not 
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completely race specific, CHF is more often associated with PSI7 for white patients than 
black patients. Age shows an inverse racial relationship (ie, high PSI7 rates are associated 
with increasing age for whites but decreasing age for blacks).
Discussion
In this study of racial disparity for PSI7 in Florida hospitals, it was found that racial 
disparity in PSI7 rates was highest in hospitals with high proportions of black discharges and 
lowest average total discharges. In addition, both common and race-specific risk factors of 
PSI7 were identified in hospital groups with a substantial black/white PSI7 rate gap. 
Numerous studies have examined racial disparities in hospital patient safety events using the 
AHRQ PSIs. These studies found that blacks had higher rates of nosocomial infections and 
some adverse surgical outcomes than whites, after risk adjusting for patient- and hospital-
level factors.6,9,25 The findings from these prior studies suggest that independent of hospital-
level variations, blacks may have specific risk factors that may explain their increased risk 
for a patient safety event. Because these factors may be race specific, the “common effect” 
risk-adjustment method used in prior research will fail to identify race-specific factors and 
may not detect racial disparities.18
The present study’s findings indicate that there is a different set of patient characteristics that 
influence the likelihood of PSI7 events for black and white patients. In hospital groups 3 and 
4, wherein the PSI7 rates are higher for blacks than whites, renal failure, perivascular 
disease, Medicaid insurance, and younger age were risk factors specific to black patients. 
The white race-specific risk factors identified in hospital group 1, wherein the PSI7 rate is 
higher for whites than blacks, include diabetes with chronic complications, chronic blood 
loss anemia, older age, and peptic ulcer/bleeding. The comorbidity profile associated with 
PSI7 in black and white patients is different, and their clinical needs may be different. These 
findings suggest the need for race-specific examination of patient safety events and provide a 
new context for examining racial disparities.
Studies have shown that for certain conditions (eg hypertension, heart failure, CHF), black 
and white patients show differences in pathophysiological and clinical characteristics and 
respond differently to some therapies.26,27 There is documented evidence of a higher burden 
of cardiovascular disease in black Americans.26 Furthermore, although multiple studies have 
suggested that the total mortality related to CHF as well as hospitalization for worsening 
CHF was higher in blacks compared with whites,28–30 it is important to recognize that there 
are striking population differences with respect to this disease in almost every aspect.29 For 
example, the cause of CHF is primarily ischemic disease in nonblack patients, but it has a 
predominantly hypertensive nature in blacks.29 Risk adjustment in racial disparity studies 
that does not consider these differences between the race groups may miss important 
characteristics that may help explain racial disparities in health outcomes and help segment 
subpopulations at risk of patient safety events.
The present study also identified a cluster of common PSI7 risk factors, comorbid 
conditions, and characteristics that are consistent across the 4 hospital groups. Although it is 
beyond the scope of this research to explain the etiology and pathophysiology of all 
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conditions identified as common and/or race specific, previous studies provide support for 
some of them. For example, weight loss, which emerged as an important predictor of PSI7, 
has been suggested as a marker of many ongoing chronic diseases and associated with 
mortality in previous studies.31 Although the list of potential causes of weight loss is 
extensive, for conditions such as gastrointestinal, hepatobiliary, hematologic, lung, breast, 
genitourinary, ovarian, and prostate malignancies, it may be a presenting feature before 
disease manifestation.32 This is an important consideration for the present study, although 
confirmed cancer and AIDS cases were excluded from the analysis; there may be patients 
with undiagnosed cancerous diseases with comorbid weight loss included in the analysis 
who would be particularly susceptible to infections, including PSI7.
The results also showed that age has an inverse relationship with PSI7 for the race groups 
examined, with older whites and younger blacks at risk for PSI7. This relationship emerged 
for whites in hospital groups 1 and 2, wherein white PSI7 rates were high, and for blacks in 
groups 3 and 4, wherein black PSI7 rates were high. Considered together, these clusters of 
comorbid risk factors and demographic characteristics suggest that racial disparity in PSI7 
across Florida hospitals is, in part, a result of differences in patient populations and race-
specific risk factors.
This research has some limitations. Clinical details such as duration of catheterization, 
adequacy of using antimicrobial agents for prevention and treatment of bloodstream 
infections, site of catheter placement, type of catheter (single vs triple lumen), and the 
severity of the comorbid conditions were not available in the data and therefore were not 
accounted for. The data did not include a “present on admission” indicator for comorbidities. 
Certain conditions such as coagulopathy and electrolyte disorders may occur during 
hospitalization and should be considered complications rather than comorbid conditions. 
Furthermore, the logistic regression analysis did not allow the identification of the effects of 
reciprocal interactions between covariates.
Conclusions
This study showed that some comorbid conditions and patient characteristics that are 
associated with a PSI7 event differ by race. Race-specific differences in patterns of 
comorbid conditions are important determinants of hospital-level patient safety outcomes.
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Figure 1. 
Study data inclusion criteria.
Abbreviations: PSI, patient safety indicator; ICD 9, International Classification of Diseases, 
Ninth Revision, Clinical Modification.
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Table 1
Patient Characteristics by Hospital Groups.
Hospital Groups (N = 5 236 045)
Group 1 (n = 19) Group 2 (n = 33) Group 3 (n = 22) Group 4 (n = 29)
Hospital discharges
Total 1 484 252 2 090 997 891 447 769 349
Black 185 838 366 232 179 739 220 986
White 1 298 414 1 724 765 711 708 548 363
Average discharges (5 years) 78 118 63 364 40 520 26 529
Race (percentage of discharges)
Black 0.13 0.18 0.20 0.29
White 0.87 0.82 0.80 0.71
PSI7 discharges
Total 2614 4191 1480 1160
Black 209 705 375 586
White 2405 3486 1105 574
PSI7 (Rate/10 000)
Black 11.24 19.25 20.86 26.52
White 18.52 20.21 15.52 10.46
Black/White PSI7 rate ratioa 0.60 0.95 1.34 2.53
Length of stay in days (mean, all patients)
Black 4.84 4.80 5.18 4.81
White 4.94 4.90 5.00 4.86
Length of stay in days (mean, PSI7 patients)
Black 14.70 14.98 14.80 15.28
White 14.30 14.19 13.96 14.05
Age (mean, all patients)
Black 47.80 45.50 48.15 47.55
White 58.66 55.55 60.80 59.04
Age (mean, PSI7 patients)
Black 50.69 49.70 47.60 46.26
White 62.18 59.70 63.50 63.80
Abbreviation: PSI, patient safety indicator.
a
Black/White PSI7 refers to the ratio of black PSI7 rate to white PSI7 rate.
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